{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:55:19Z","timestamp":1787072119186,"version":"build-2736575974"},"reference-count":48,"publisher":"American Chemical Society (ACS)","issue":"32","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["2023JH2\/101700094"],"award-info":[{"award-number":["2023JH2\/101700094"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["2024YFA0919100"],"award-info":[{"award-number":["2024YFA0919100"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303766"],"award-info":[{"award-number":["82303766"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473143"],"award-info":[{"award-number":["82473143"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82525069"],"award-info":[{"award-number":["82525069"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The development of proteolysis-targeting chimeras (PROTACs) represents a promising strategy for targeted protein degradation in cancer therapy. However, the limited tumor-specific targeting and the inherent unfavorable physicochemical properties of PROTACs lead to insufficient cellular uptake and suboptimal antitumor immune responses. Herein, as a proof of concept, we developed an oncolytic virus-PROTAC conjugate (BPAD) by efficiently coupling bromodomain-containing protein 4 (BRD4)-targeting PROTACs with oncolytic viruses (OVs). In BPAD, the potent and highly selective infection of OVs to tumor cells enhances both cellular uptake and tumor-selective delivery of PROTACs, resulting in a 640-fold increase in the protein degradation efficiency. Moreover, prior to OV-induced tumor lysis, the preferential replication of OVs within tumor cells, combined with BRD4 degradation, promotes the secretion of type I interferons and facilitates dendritic cell maturation. Overall, the BPAD strategy enables the development of biologically derived macromolecular PROTAC conjugates, thereby enhancing the clinical translation potential of diverse PROTACs.<\/jats:p>","DOI":"10.1021\/acsnano.5c21715","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:01:25Z","timestamp":1786032085000},"page":"22391-22412","source":"Crossref","is-referenced-by-count":0,"title":["Development of Oncolytic\nVirus-Proteolysis-Targeting\nChimera Conjugates for Tumor Immunotherapy"],"prefix":"10.1021","volume":"20","author":[{"given":"Zhixiong","family":"Gao","sequence":"first","affiliation":[{"name":"The First Hospital of China Medical University , , 155 North Nanjing Street , Heping District, ,","place":["Shenyang, China, 110001"]},{"name":"China Medical University , , 155 North Nanjing Street , Heping District, ,","place":["Shenyang, China, 110001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwei","family":"Huang","sequence":"additional","affiliation":[{"name":"The First Hospital of China Medical University , , 155 North Nanjing Street , Heping District, ,","place":["Shenyang, China, 110001"]},{"name":"China Medical University , , 155 North Nanjing Street , Heping District, ,","place":["Shenyang, China, 110001"]},{"name":"The First Hospital, China Medical University , , 518 North Chuangxin Road, Baita Street , Hunnan District, , ,","place":["Shenyang, Liaoning, China, 110102"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7935-2855","authenticated-orcid":true,"given":"Ying","family":"Zhi","sequence":"additional","affiliation":[{"name":"Shandong First Medical University & Shandong Academy of Medical Sciences , , ,","place":["Jinan, China, 250117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Wu","sequence":"additional","affiliation":[{"name":"The First Hospital of China Medical University , , 155 North Nanjing Street , Heping District, ,","place":["Shenyang, China, 110001"]},{"name":"Xuzhou Medical University , , , ,","place":["Xuzhou, Jiangsu, China, 221002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcheng","family":"Guo","sequence":"additional","affiliation":[{"name":"Shandong First Medical University & Shandong Academy of Medical Sciences , , ,","place":["Jinan, China, 250117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhao","family":"Dong","sequence":"additional","affiliation":[{"name":"Shandong First Medical University & Shandong Academy of Medical Sciences , , ,","place":["Jinan, China, 250117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Du","sequence":"additional","affiliation":[{"name":"The First Hospital of China Medical University , , 155 North Nanjing Street , Heping District, ,","place":["Shenyang, China, 110001"]},{"name":"China Medical University , , 155 North Nanjing Street , Heping District, ,","place":["Shenyang, China, 110001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zao","family":"Ji","sequence":"additional","affiliation":[{"name":"The First Hospital of China Medical University , , 155 North Nanjing Street , Heping District, ,","place":["Shenyang, China, 110001"]},{"name":"China Medical University , , 155 North Nanjing Street , Heping District, ,","place":["Shenyang, China, 110001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihua","family":"Yang","sequence":"additional","affiliation":[{"name":"The First Hospital of China Medical University , , 155 North Nanjing Street , Heping District, ,","place":["Shenyang, China, 110001"]},{"name":"China Medical University , , 155 North Nanjing Street , Heping District, ,","place":["Shenyang, China, 110001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohe","family":"Wang","sequence":"additional","affiliation":[{"name":"Queen Mary University of London , , ,","place":["London, U.K., EC1M 6BQ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Cheng","sequence":"additional","affiliation":[{"name":"Queen Mary University of London , , ,","place":["London, U.K., EC1M 6BQ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5453-5882","authenticated-orcid":true,"given":"Huiling","family":"Gao","sequence":"additional","affiliation":[{"name":"Northeastern University , , ,","place":["Shenyang, China, 110169"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Jiang","sequence":"additional","affiliation":[{"name":"Shandong University , , 44 Cultural West Road , , ,","place":["Jinan, Shandong Province, China, 250012"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[{"name":"Shengjing Hospital of China Medical University , , ,","place":["Shenyang, China, 110004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Shandong University , , 44 Cultural West Road , , ,","place":["Jinan, Shandong Province, China, 250012"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4762-8279","authenticated-orcid":true,"given":"Funan","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Hospital of China Medical University , , 155 North Nanjing Street , Heping District, ,","place":["Shenyang, China, 110001"]},{"name":"China Medical University , , 155 North Nanjing Street , Heping District, ,","place":["Shenyang, China, 110001"]},{"name":"The First Hospital, China Medical University , , 518 North Chuangxin Road, Baita Street , Hunnan District, , ,","place":["Shenyang, Liaoning, China, 110102"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"3","key":"2026081810312610500_cit1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders:\nthe past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"1","key":"2026081810312610500_cit2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-021-01434-3","article-title":"Proteolysis-targeting\nchimeras (PROTACs) in cancer therapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"},{"issue":"Pt 1","key":"2026081810312610500_cit3","doi-asserted-by":"publisher","first-page":"133680","DOI":"10.1016\/j.ijbiomac.2024.133680","article-title":"Progress of proteolysis-targeting\nchimeras (PROTACs) delivery system in tumor treatment","volume":"275","author":"Fan","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"6715","key":"2026081810312610500_cit4","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1126\/science.adm8684","article-title":"Targeting\ncancer with small-molecule pan-KRAS degraders","volume":"385","author":"Popow","year":"2024","journal-title":"Science"},{"issue":"7893","key":"2026081810312610500_cit5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-021-04246-z","article-title":"Targeting\nSWI\/SNF ATPases in enhancer-addicted prostate cancer","volume":"601","author":"Xiao","year":"2022","journal-title":"Nature"},{"issue":"13","key":"2026081810312610500_cit6","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1039\/D1CS00762A","article-title":"Proteolysis-targeting\nchimera (PROTAC) delivery system: advancing\nprotein degraders towards clinical translation","volume":"51","author":"Chen","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"2026081810312610500_cit7","doi-asserted-by":"publisher","first-page":"103395","DOI":"10.1016\/j.drudis.2022.103395","article-title":"PROTAC\ntechnology: A new drug design for chemical biology with many challenges\nin drug discovery","volume":"28","author":"Guedeney","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"14","key":"2026081810312610500_cit8","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1039\/D2CS00200K","article-title":"Target\nand tissue selectivity of PROTAC degraders","volume":"51","author":"Guenette","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"10","key":"2026081810312610500_cit9","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1039\/D2CS00141A","article-title":"Degrader-antibody\nconjugates","volume":"51","author":"Dragovich","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"2026081810312610500_cit10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41557-023-01379-8","article-title":"Proteolysis-targeting\nchimeras with reduced off-targets","volume":"16","author":"Nguyen","year":"2024","journal-title":"Nat. Chem."},{"issue":"39","key":"2026081810312610500_cit11","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202306824","article-title":"Stimuli-Responsive\nPROTACs for Controlled Protein Degradation","volume":"62","author":"An","year":"2023","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"2026081810312610500_cit12","doi-asserted-by":"publisher","first-page":"216128","DOI":"10.1016\/j.canlet.2023.216128","article-title":"PROTACs: Novel tools for improving\nimmunotherapy in cancer","volume":"560","author":"Li","year":"2023","journal-title":"Cancer Lett."},{"issue":"6","key":"2026081810312610500_cit13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00018-023-04796-7","article-title":"Development of VHL-recruiting\nSTING PROTACs that suppress innate immunity","volume":"80","author":"Zhu","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"2026081810312610500_cit14","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.3389\/fimmu.2018.02697","article-title":"Specific\nMHC-I Peptides Are Induced Using PROTACs","volume":"9","author":"Jensen","year":"2018","journal-title":"Front.\nImmunol."},{"issue":"9","key":"2026081810312610500_cit15","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses:\na new class of\nimmunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"1","key":"2026081810312610500_cit16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","article-title":"Oncolytic\nvirotherapy: basic principles,\nrecent advances and future directions","volume":"8","author":"Lin","year":"2023","journal-title":"Signal\nTransduction Targeted Ther."},{"issue":"8","key":"2026081810312610500_cit17","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.annonc.2021.03.197","article-title":"Oncolytic virus in\ngliomas: a review of human clinical investigations","volume":"32","author":"Carpenter","year":"2021","journal-title":"Ann. Oncol."},{"issue":"2","key":"2026081810312610500_cit18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field\nof oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends Cancer"},{"issue":"Pt 3","key":"2026081810312610500_cit19","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.semcancer.2021.06.021","article-title":"Virus-inspired\nstrategies\nfor cancer therapy","volume":"86","author":"Ma","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"2026081810312610500_cit20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41392-022-00921-3","article-title":"Identification of the receptor of oncolytic\nvirus M1 as a therapeutic\npredictor for multiple solid tumors","volume":"7","author":"Song","year":"2022","journal-title":"Signal\nTransduction Targeted Ther."},{"issue":"2","key":"2026081810312610500_cit21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.stem.2019.11.016","article-title":"Zika Virus\nTargets Glioblastoma Stem Cells through\na SOX2-Integrin \u03b1v\u03b25 Axis","volume":"26","author":"Zhu","year":"2020","journal-title":"Cell\nStem Cell"},{"issue":"11","key":"2026081810312610500_cit22","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s43018-022-00448-0","article-title":"Specific targeting of glioblastoma\nwith an oncolytic virus expressing a cetuximab-CCL5 fusion protein\nvia innate and adaptive immunity","volume":"3","author":"Tian","year":"2022","journal-title":"Nat. Cancer"},{"issue":"18","key":"2026081810312610500_cit23","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/gt.2008.58","article-title":"Inflammatory tumour cell killing\nby oncolytic reovirus for the treatment of melanoma","volume":"15","author":"Errington","year":"2008","journal-title":"Gene Ther."},{"issue":"42","key":"2026081810312610500_cit24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1408759111","article-title":"Identification and characterization of alphavirus\nM1 as a selective\noncolytic virus targeting ZAP-defective human cancers","volume":"111","author":"Lin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"2026081810312610500_cit25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s40478-020-01096-0","article-title":"Characterization and oncolytic virus targeting\nof FAP-expressing tumor-associated pericytes in glioblastoma","volume":"8","author":"Li","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"issue":"5","key":"2026081810312610500_cit26","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/mt.2011.26","article-title":"Targeting\ntumor vasculature with an oncolytic virus","volume":"19","author":"Breitbach","year":"2011","journal-title":"Mol.\nTher."},{"key":"2026081810312610500_cit27","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cell.2024.12.010","article-title":"Hyperacute rejection-engineered oncolytic virus for interventional\nclinical trial in refractory cancer patients","volume":"188","author":"Zhong","year":"2025","journal-title":"Cell"},{"issue":"8062","key":"2026081810312610500_cit28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-025-08717-5","article-title":"Oncolytic\nvirus VG161 in refractory hepatocellular\ncarcinoma","volume":"641","author":"Shen","year":"2025","journal-title":"Nature"},{"issue":"1","key":"2026081810312610500_cit29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1535-6108(03)00170-3","article-title":"Getting oncolytic\nvirus therapies\noff the ground","volume":"4","author":"Bell","year":"2003","journal-title":"Cancer Cell"},{"issue":"1","key":"2026081810312610500_cit30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41392-022-00951-x","article-title":"Engineering\nstrategies to enhance oncolytic viruses\nin cancer immunotherapy","volume":"7","author":"Tian","year":"2022","journal-title":"Signal Transduction\nTargeted Ther."},{"issue":"1","key":"2026081810312610500_cit31","doi-asserted-by":"publisher","first-page":"7504","DOI":"10.1038\/s41598-019-43668-8","article-title":"A tumor targeting\noncolytic adenovirus can improve therapeutic outcomes in chemotherapy\nresistant metastatic human breast carcinoma","volume":"9","author":"Sakhawat","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"2026081810312610500_cit32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/cgt.2008.103","article-title":"Expression and function of the coxsackie\nand adenovirus\nreceptor in Barrett\u2019s esophagus and associated neoplasia","volume":"16","author":"Anders","year":"2009","journal-title":"Cancer Gene The.r"},{"issue":"9","key":"2026081810312610500_cit33","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2010.47","article-title":"Expression of coxsackie\nand adenovirus\nreceptor distinguishes transitional cancer states in therapy-induced\ncellular senescence","volume":"1","author":"Wu","year":"2010","journal-title":"Cell Death Dis."},{"issue":"7","key":"2026081810312610500_cit34","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1038\/bjc.2013.509","article-title":"Presence of the coxsackievirus\nand adenovirus receptor\n(CAR) in human neoplasms: a multitumour array analysis","volume":"109","author":"Reeh","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"13","key":"2026081810312610500_cit35","first-page":"3812","article-title":"Expression\nof the coxsackie adenovirus receptor in normal prostate and in primary\nand metastatic prostate carcinoma: potential relevance to gene therapy","volume":"62","author":"Rauen","year":"2002","journal-title":"Cancer Res."},{"issue":"12","key":"2026081810312610500_cit36","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1158\/1078-0432.CCR-04-2370","article-title":"Coxsackie and adenovirus receptor\npromotes adenocarcinoma cell survival and is expressionally activated\nafter transition from preneoplastic precursor lesions to invasive\nadenocarcinomas","volume":"11","author":"Bruning","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"2026081810312610500_cit37","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/pharmaceutics12100986","article-title":"Controlled Delivery of BET-PROTACs: In Vitro Evaluation of MZ1-Loaded\nPolymeric Antibody Conjugated Nanoparticles in Breast Cancer","volume":"12","author":"Cimas","year":"2020","journal-title":"Pharmaceutics"},{"issue":"11","key":"2026081810312610500_cit38","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1002\/hed.26827","article-title":"PD-L1 is upregulated\nvia BRD2 in head and neck squamous cell carcinoma models of acquired\ncetuximab resistance","volume":"43","author":"Bhola","year":"2021","journal-title":"Head Neck"},{"key":"2026081810312610500_cit39","doi-asserted-by":"publisher","first-page":"1505255","DOI":"10.3389\/fmolb.2024.1505255","article-title":"Precision-engineered\nPROTACs minimize off-tissue effects in cancer therapy","volume":"11","author":"Shi","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"2026081810312610500_cit40","doi-asserted-by":"publisher","first-page":"728082","DOI":"10.3389\/fimmu.2021.728082","article-title":"Brd4 Regulates the Homeostasis of CD8(+) T-Lymphocytes\nand Their Proliferation in Response to Antigen Stimulation","volume":"12","author":"Peng","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"2026081810312610500_cit41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008429","article-title":"BRD4 inhibition\nexerts anti-viral activity through DNA damage-dependent innate immune\nresponses","volume":"16","author":"Wang","year":"2020","journal-title":"PLoS Pathog."},{"issue":"1","key":"2026081810312610500_cit42","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-021-00554-y","article-title":"Cytosolic DNA sensing\nby cGAS: regulation, function, and human diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduction Targeted Ther."},{"issue":"7713","key":"2026081810312610500_cit43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","article-title":"Targeting\nSTING with\ncovalent small-molecule inhibitors","volume":"559","author":"Haag","year":"2018","journal-title":"Nature"},{"issue":"9","key":"2026081810312610500_cit44","first-page":"2088","article-title":"Inhibition of the Raf\/MEK\/ERK pathway up-regulates\nexpression of the coxsackievirus and adenovirus receptor in cancer\ncells","volume":"63","author":"Anders","year":"2003","journal-title":"Cancer Res."},{"issue":"4","key":"2026081810312610500_cit45","first-page":"847","article-title":"Modulation\nof coxsackie-adenovirus\nreceptor expression for increased adenoviral transgene expression","volume":"63","author":"Hemminki","year":"2003","journal-title":"Cancer Res."},{"issue":"15","key":"2026081810312610500_cit46","doi-asserted-by":"publisher","first-page":"14461","DOI":"10.1021\/acsnano.3c00847","article-title":"Virus-Protein Corona Replacement\nStrategy to Improve the Antitumor Efficacy of Intravenously Injected\nOncolytic Adenovirus","volume":"17","author":"Huang","year":"2023","journal-title":"ACS Nano"},{"issue":"5","key":"2026081810312610500_cit47","doi-asserted-by":"publisher","first-page":"102078","DOI":"10.1016\/j.xcrm.2025.102078","article-title":"Tailoring an intravenously injectable\noncolytic virus for augmenting radiotherapy","volume":"6","author":"Xu","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"5","key":"2026081810312610500_cit48","doi-asserted-by":"publisher","first-page":"2303907","DOI":"10.1002\/advs.202303907","article-title":"Erythrocyte-Leveraged Oncolytic Virotherapy (ELeOVt): Oncolytic Virus\nAssembly on Erythrocyte Surface to Combat Pulmonary Metastasis and\nAlleviate Side Effects","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci."}],"container-title":["ACS Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsnano.5c21715","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/ancac3\/article-pdf\/20\/32\/22391\/66447231\/acsnano.5c21715.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/ancac3\/article-pdf\/20\/32\/22391\/66447231\/acsnano.5c21715.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:21:48Z","timestamp":1787070108000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/ancac3\/article\/20\/32\/22391\/5249648\/Development-of-Oncolytic-Virus-Proteolysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":48,"journal-issue":{"issue":"32","published-online":{"date-parts":[[2026,8,6]]},"published-print":{"date-parts":[[2026,8,18]]}},"URL":"https:\/\/doi.org\/10.1021\/acsnano.5c21715","relation":{},"ISSN":["1936-0851","1936-086X"],"issn-type":[{"value":"1936-0851","type":"print"},{"value":"1936-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}